MAPK/ERK kinase inhibitors


Ontology type: sgo:Patent     


Patent Info

DATE

2009-11-04T00:00

AUTHORS

ADAMS MARK E , DONG QING , KALDOR STEPHEN W , KANOUNI TOUFIKE , WALLACE MICHAEL B

ABSTRACT

Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound of formula: wherein the variables are as defined herein.

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/34", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/46", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/4613", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "name": "ADAMS MARK E", 
        "type": "Person"
      }, 
      {
        "name": "DONG QING", 
        "type": "Person"
      }, 
      {
        "name": "KALDOR STEPHEN W", 
        "type": "Person"
      }, 
      {
        "name": "KANOUNI TOUFIKE", 
        "type": "Person"
      }, 
      {
        "name": "WALLACE MICHAEL B", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1038/sj.onc.1202367", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035710963", 
          "https://doi.org/10.1038/sj.onc.1202367"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/nrc1503", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033502588", 
          "https://doi.org/10.1038/nrc1503"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/343651a0", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015375932", 
          "https://doi.org/10.1038/343651a0"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2009-11-04T00:00", 
    "description": "

Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound of formula:\n\nwherein the variables are as defined herein.

", "id": "sg:patent.EP-2113500-A1", "name": "MAPK/ERK kinase inhibitors", "recipient": [ { "id": "http://www.grid.ac/institutes/grid.419841.1", "type": "Organization" } ], "sameAs": [ "https://app.dimensions.ai/details/patent/EP-2113500-A1" ], "sdDataset": "patents", "sdDatePublished": "2022-12-01T06:58", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221201/entities/gbq_results/patent/patent_25.jsonl", "type": "Patent" } ]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/patent.EP-2113500-A1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/patent.EP-2113500-A1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/patent.EP-2113500-A1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/patent.EP-2113500-A1'


 

This table displays all metadata directly associated to this object as RDF triples.

56 TRIPLES      14 PREDICATES      19 URIs      8 LITERALS      2 BLANK NODES

Subject Predicate Object
1 sg:patent.EP-2113500-A1 schema:about anzsrc-for:34
2 anzsrc-for:46
3 anzsrc-for:4613
4 schema:author N96eb2568f23b42fc9cdb1eb7a7200e26
5 schema:citation sg:pub.10.1038/343651a0
6 sg:pub.10.1038/nrc1503
7 sg:pub.10.1038/sj.onc.1202367
8 schema:datePublished 2009-11-04T00:00
9 schema:description <p num="pa01">Compounds, pharmaceutical compositions, kits and methods are provided for use with MEK that comprise a compound of formula: <chemistry id="chema01" num="0001"><img id="ia01" file="imga0001.tif" wi="47" he="38" img-content="chem" img-format="tif"/></chemistry> wherein the variables are as defined herein.</p>
10 schema:name MAPK/ERK kinase inhibitors
11 schema:recipient grid-institutes:grid.419841.1
12 schema:sameAs https://app.dimensions.ai/details/patent/EP-2113500-A1
13 schema:sdDatePublished 2022-12-01T06:58
14 schema:sdLicense https://scigraph.springernature.com/explorer/license/
15 schema:sdPublisher N3ffdbaa677dd46129874fa9c1b5e943e
16 sgo:license sg:explorer/license/
17 sgo:sdDataset patents
18 rdf:type sgo:Patent
19 N0a03275abf0d414cbc458a23106d9df0 schema:name KANOUNI TOUFIKE
20 rdf:type schema:Person
21 N11a6795dfc124814a8a46768e7a87835 rdf:first N1cf89f9c0f114aadb9a19bb07564106c
22 rdf:rest N6755b6dad5284515a0cfb476c5eb810a
23 N1cf89f9c0f114aadb9a19bb07564106c schema:name KALDOR STEPHEN W
24 rdf:type schema:Person
25 N25064f89f98d4721889be6da48750a2a rdf:first N7653b871a00c47429c3e56e56256cad2
26 rdf:rest N11a6795dfc124814a8a46768e7a87835
27 N3ffdbaa677dd46129874fa9c1b5e943e schema:name Springer Nature - SN SciGraph project
28 rdf:type schema:Organization
29 N6755b6dad5284515a0cfb476c5eb810a rdf:first N0a03275abf0d414cbc458a23106d9df0
30 rdf:rest N946beb4dbbe6492ba60cef32528560b4
31 N7653b871a00c47429c3e56e56256cad2 schema:name DONG QING
32 rdf:type schema:Person
33 N946beb4dbbe6492ba60cef32528560b4 rdf:first Nad2b71234eaf4560800c1204b6bf218d
34 rdf:rest rdf:nil
35 N96eb2568f23b42fc9cdb1eb7a7200e26 rdf:first Ne070acadcd204982b9bcb7bc403de47e
36 rdf:rest N25064f89f98d4721889be6da48750a2a
37 Nad2b71234eaf4560800c1204b6bf218d schema:name WALLACE MICHAEL B
38 rdf:type schema:Person
39 Ne070acadcd204982b9bcb7bc403de47e schema:name ADAMS MARK E
40 rdf:type schema:Person
41 anzsrc-for:34 schema:inDefinedTermSet anzsrc-for:
42 rdf:type schema:DefinedTerm
43 anzsrc-for:46 schema:inDefinedTermSet anzsrc-for:
44 rdf:type schema:DefinedTerm
45 anzsrc-for:4613 schema:inDefinedTermSet anzsrc-for:
46 rdf:type schema:DefinedTerm
47 sg:pub.10.1038/343651a0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015375932
48 https://doi.org/10.1038/343651a0
49 rdf:type schema:CreativeWork
50 sg:pub.10.1038/nrc1503 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033502588
51 https://doi.org/10.1038/nrc1503
52 rdf:type schema:CreativeWork
53 sg:pub.10.1038/sj.onc.1202367 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035710963
54 https://doi.org/10.1038/sj.onc.1202367
55 rdf:type schema:CreativeWork
56 grid-institutes:grid.419841.1 schema:Organization
 




Preview window. Press ESC to close (or click here)


...